ArticleOncotarget2016
Identification of a structurally novel BTK mutation that drives ibrutinib resistance in CLL.
Shruti Sharma et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
52 papers cite it
this paperpooled ittrialcites it